Debiopharm Digitalizes Preclinical Research
Ferring: From mAbs to Therapeutic Microbiomes
Informing Immunotherapy Clinical Development with Biomarkers
Automating MS Analysis of Oligonucleotide Biotransformations
Ajinomoto Speeds up Cell Culture Media Development Projects with Genedata Bioprocess
Sartorius Accelerates Development Processes by a Factor of 3
Pfizer Builds on the Genedata Biopharma E2E Workflow Platform
Immatics Digitalizes CGT Discovery with Genedata Biologics
MorphoSys Advances Antibody R&D with Biologics
Characterizing Complex Glycosylated Biotherapeutics
Crohn’s & Colitis Foundation Identifies Pediatric Crohn’s Disease Biomarkers
Astellas Uses Genedata Profiler to Unlock Insights from RWD
Driving R&D Innovation through Partnerships
Automating MS-Based Analytics of Novel Therapeutic Oligos
Fully Automated HT HCP Analysis of Highly Diverse Samples
Automating QC of Therapeutic Oligonucleotides
N-Glycosylation Monitoring of Biopharmaceuticals
Assessing Developability of Novel Biotherapeutics
MAM Validation in Biopharma Process Characterization
Streamlining MS-based Analysis of Novel Biotherapeutics
Secure Data Is FAIR(er) Data
Data-Driven Decisions to Accelerate Biopharma R&D
MorphoSys Digitalizes Large-Molecule R&D
Kymab Automates Lab Operations with Genedata
Janssen, Celgene, and Aptevo Streamline Discovery Operations
A Single Source of Truth for Biopharma Discovery Data
A Discovery Platform that Automates Daily Work
Harmonizing & Standardizing Discovery Operations
A Proven Data Backbone for Biopharma Operations
A Constantly Evolving Discovery Platform
A Central Data Infrastructure for Decision-Making
Enabling In-depth MS-based Characterization of Biopharmaceuticals
Implementing MAM for Biotherapeutic Characterization
Automated Data Processing for a Novel MS-Based HTS Platform
